Figure 5.
Proportion of participants in canagliflozin cardiovascular safety study in patients with T2DM experiencing a ≥1-step progression in albuminuria stage.
Source: Coelln-Hough et al.92
T2DM: type 2 diabetes mellitus.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.